Zacks Research Has Bullish Estimate for Integer Q1 Earnings

Integer Holdings Co. (NYSE:ITGR) – Investment analysts at Zacks Research raised their Q1 2025 earnings per share estimates for shares of Integer in a research note issued on Thursday, December 5th. Zacks Research analyst D. Dey now expects that the medical equipment provider will earn $1.31 per share for the quarter, up from their prior estimate of $1.30. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q2 2025 earnings at $1.43 EPS, Q3 2025 earnings at $1.55 EPS, Q4 2025 earnings at $1.68 EPS, FY2025 earnings at $5.97 EPS and FY2026 earnings at $6.59 EPS.

Other equities analysts have also recently issued research reports about the company. Piper Sandler reissued an “overweight” rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. Truist Financial lowered their price target on Integer from $150.00 to $147.00 and set a “buy” rating for the company in a report on Friday, October 25th. Bank of America boosted their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Citigroup boosted their price target on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Finally, Benchmark boosted their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, Integer has a consensus rating of “Moderate Buy” and a consensus price target of $142.00.

Integer Price Performance

Integer stock opened at $139.66 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer has a 52 week low of $89.65 and a 52 week high of $142.76. The stock has a market capitalization of $4.68 billion, a P/E ratio of 43.10, a price-to-earnings-growth ratio of 2.00 and a beta of 1.12. The stock has a fifty day moving average of $132.80 and a 200-day moving average of $125.29.

Integer (NYSE:ITGR) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.27 EPS.

Hedge Funds Weigh In On Integer

Institutional investors and hedge funds have recently bought and sold shares of the company. Contravisory Investment Management Inc. increased its stake in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 80 shares during the period. HighTower Advisors LLC increased its stake in shares of Integer by 0.8% in the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock valued at $1,579,000 after buying an additional 90 shares during the period. Xponance Inc. increased its stake in shares of Integer by 4.9% in the second quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after buying an additional 99 shares during the period. Azzad Asset Management Inc. ADV increased its stake in shares of Integer by 0.9% in the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock valued at $1,504,000 after buying an additional 107 shares during the period. Finally, GAMMA Investing LLC increased its stake in shares of Integer by 60.9% in the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after buying an additional 142 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.